Company performance
Add to research
Current Price
as of Mar 13, 2025$22.36
P/E Ratio
N/A
Market Cap
$244.92M
Loading...
Description
Add to research
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Other
- TickerCDTX
- Price$22.36-2.78%
Trading Information
- Market cap$244.92M
- Float62.52%
- Average Daily Volume (1m)103,342
- Average Daily Volume (3m)106,641
- EPS-$26.46
Company
- Revenue$1.28M
- Rev growth (1yr)-98.00%
- Net income-$170.29M
- Gross margin81.73%
- EBITDA margin-7,136.16%
- EBITDA-$90.99M
- EV-$21.92M
- EV/Revenue-17.19
- P/EN/A
- P/S111.36
- P/B1.50
- Debt/Equity2.19
Documents
Add to research
SEC Filings
Factset Street Account
Factset